The monarch shared what "can help" while speaking with a student undergoing cancer treatment Janine Henni is a Royals Staff Writer for PEOPLE Digital, covering modern monarchies and the world's ...

Before the treatment, 82% of participants reported ODI scores that placed them in the “severe” or “crippled” category. By 12 months, that number had dropped to 18%.

Until now, the only effective long-term treatment for the rare metabolic disease known as severe Carbamoyl Phosphate Synthetase 1 deficiency, or CPS1, had been a liver transplant. Instead ...

NEWS NINE. THE TOWN OF MILFORD MAKING UPGRADES TO ITS WASTEWATER TREATMENT PLANT TO HELP REDUCE THE LEVEL OF CHEMICALS AND METAL IN WATER THAT GOES INTO THE SOUHEGAN RIVER. THAT WATER THEN GOES ...

Getting treatment to KJ quickly was critical for doctors. Researchers at the University of California, Berkeley and the Children’s Hospital of Philadelphia worked together to test a CRISPR base ...

Instead, KJ has made medical history. The baby, now 9 ½ months old, became the first patient of any age to have a custom gene-editing treatment, according to his doctors. He received an infusion ...

The vagus nerve runs from the brain to the large intestine, and controls involuntary functions including digestion and your mood This new treatment works in tandem with a traditional PTSD ...

Some experts say involuntary addiction treatment raises serious ethical concerns and could even increase the risk of overdose for some, as Ontario weighs whether it could mandate treatment for ...

The most common adverse events in both treatment groups were gastrointestinal, and most were mild to moderate in severity and occurred primarily during dose escalation. Among participants with ...

The Treatment is a compelling listen to the vital conversations about the catalysts of creative inspiration. Following some of the most interesting, influential, and crossover creators in the ...

Little KJ Muldoon, now nearly ten months old, is doing well after receiving three doses of a gene-editing treatment to mend a mutation that impaired his body’s ability to process protein ...

"I had been waiting for a clinical trial," recalled Dimery, now 35. "I had exhausted every other standard of treatment, and even some not-so-standard ones." When Dimery heard about a new trial at ...